Pfizer's Says Company "Very" Big Balance Sheet for Deals
Pfizer signals it can bankroll ambitious deals with a robust balance sheet. This article weighs what a 'very big' bal...
Understand why methodology matters in investing and how it affects risk assessment, accuracy, and investment outcomes.
21,903 articlesPfizer signals it can bankroll ambitious deals with a robust balance sheet. This article weighs what a 'very big' bal...
As UCB prepares to reveal Q2 results, investors should focus on revenue mix, pipeline progress, and margin resilience...
A major fund reported a sizeable exit from an offshore energy stake, triggering a review of how investors manage risk...
Learning to find high-cash-flow vacation rentals isn’t about luck. This guide shows a loan-friendly approach using pr...
New Jersey’s real estate scene is buzzing even with steep taxes and living costs. This article breaks down the demand...
Investors eyes turn to NextNav as 2025 earnings loom. This guide breaks down what to watch, potential growth drivers,...
A senior executive at Ziff Davis sold a sizable block of shares. This article dives into what that move could mean fo...
As the stock market today, june shows a notable move in the EV battery race. QuantumScape rallied after announcing a ...
Markets can climb for years, but today’s warning signs hint at a tougher road ahead. This guide breaks down the histo...
On March 2, Ondas surged on news of a $10 million strategic investment and a World View defense partnership. This art...
A discount retailer is stacking double-digit comps on top of double-digit comps. This article breaks down what that m...
Take a practical tour of arcutis (arqt) 2026 earnings, from revenue mix and margins to pipeline progress and risk fac...